Sacha Bodin

Publications

• Development of Radiopharmaceuticals for NPY Receptor-5 (Y5) Nuclear Imaging in Tumors by Synthesis of Specific Agonists and Investigation of Their Binding Mode
  Sacha Bodin, Lisa C. Peuker, Emmanuelle Jestin, Isabel D. Alves, Valérie Velasco, Imade Ait-Arsa, Romain Schollhammer, Frédéric Lamare, Delphine Vimont, Gaétan MacGrogan, Elif Hindié, Annette G. Beck-Sickinger, Clément Morgat.
  Bioconjugate Chem.. 2023-08-09. 34(11) : 2014-2021.
  10.1021/acs.bioconjchem.3c00313
• N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake
  Sacha Bodin, Tyrillshall S. T. Damiana, Santo Previti, Laure Balasse, Lina Ali, Emmanuelle Rémond, Vincent Nail, Frédéric Lamare, Elif Hindié, Benjamin Guillet, Delphine Vimont, Simone U. Dalm, Florine Cavelier, Clément Morgat.
  J. Med. Chem.. 2025-03-20. 68(7) : 7280-7290.
  10.1021/acs.jmedchem.4c02844
• Design and Synthesis of 68Ga‐Labeled Peptide‐Based Heterodimers for Dual Targeting of NTS1 and GRPR
  Sacha Bodin, Santo Previti, Emmanuelle Jestin, Emmanuelle Rémond, Delphine Vimont, Frédéric Lamare, Imade Ait‐Arsa, Elif Hindié, Florine Cavelier, Clément Morgat.
  ChemMedChem. 2025-02-16.
  10.1002/cmdc.202400843
• Rational design of NT-PSMA heterobivalent probes for prostate cancer theranostics
  Santo Previti, Sacha Bodin, Emmanuelle Rémond, Delphine Vimont, Elif Hindié, Clément Morgat, Florine Cavelier.
  RSC Med. Chem.. 2024-01-01. 15(12) : 4153-4158.
  10.1039/d4md00491d
• Modular One-Pot Strategy for the Synthesis of Heterobivalent Tracers
  Thibaud Bailly, Sacha Bodin, Victor Goncalves, Franck Denat, Clément Morgat, Aurélie Prignon, Ibai E. Valverde.
  ACS Med. Chem. Lett.. 2023-04-21.
  10.1021/acsmedchemlett.3c00057
• Design, Synthesis, and Biological Evaluation of the First Radio-Metalated Neurotensin Analogue Targeting Neurotensin Receptor 2
  Sacha Bodin, Santo Previti, Emmanuelle Jestin, Delphine Vimont, Imade Ait-Arsa, Frédéric Lamare, Emmanuelle Rémond, Elif Hindié, Florine Cavelier, Clément Morgat.
  ACS Omega. 2023-02-10. 8(7) : 6994-7004.
  10.1021/acsomega.2c07814